MedPath

Magna Pharmaceuticals, Inc.

Magna Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Private
Established
1990-01-01
Employees
11
Market Cap
-
Website
https://www.magnaweb.com

Clinical Trials

5

Active:0
Completed:3

Trial Phases

3 Phases

Phase 1:2
Phase 2:2
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (40.0%)
Phase 2
2 (40.0%)
Phase 3
1 (20.0%)

StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study

Phase 2
Conditions
Rhinitis, Seasonal, Allergic
Interventions
Drug: PSE 120 mg, CM 8 mg, Atr 0.36 mg
Drug: PSE 120 mg, CM 8 mg, Atr 0.24 mg
Drug: PSE 120 mg, CM 8 mg, Atr 0.12 mg
Drug: PSE 120 mg, CM 8 mg
First Posted Date
2014-03-10
Last Posted Date
2014-05-30
Lead Sponsor
Magna Pharmaceuticals, Inc.
Target Recruit Count
125
Registration Number
NCT02082054
Locations
🇺🇸

Clinical Research Atlanta, Stockbridge, Georgia, United States

🇺🇸

Family Allergy and Asthma Institute, Louisville, Kentucky, United States

🇺🇸

National Allergy, Asthma & Urticaria Centers of Charleston, PA, Charleston, South Carolina, United States

and more 1 locations

Trial of STAHIST in Seasonal Allergic Rhinitis

Phase 3
Completed
Conditions
Seasonal Allergic Rhinitis
Interventions
Drug: STAHIST
Drug: Placebo
First Posted Date
2011-02-10
Last Posted Date
2011-09-02
Lead Sponsor
Magna Pharmaceuticals, Inc.
Target Recruit Count
290
Registration Number
NCT01293201
Locations
🇺🇸

Clinical Research Atlanta, Stockbridge, Georgia, United States

🇺🇸

The South Bend Clinic, South Bend, Indiana, United States

🇺🇸

Family Allergy and Asthma Institute, Louisville, Kentucky, United States

and more 5 locations

Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects

Phase 2
Completed
Conditions
Seasonal Allergic Rhinitis
Interventions
Drug: Placebo
Drug: STAHIST
First Posted Date
2010-07-28
Last Posted Date
2014-03-26
Lead Sponsor
Magna Pharmaceuticals, Inc.
Target Recruit Count
100
Registration Number
NCT01171664
Locations
🇺🇸

The South Bend Clinic, South Bend, Indiana, United States

🇺🇸

Family Allergy & Asthma Research Institute, Louisville, Kentucky, United States

Study of AHIST in Seasonal Allergic Rhinitis Patients

Phase 1
Withdrawn
Conditions
Rhinitis, Allergic, Seasonal
Interventions
Drug: AHIST NDC#58407-012-01
First Posted Date
2009-11-05
Last Posted Date
2014-03-06
Lead Sponsor
Magna Pharmaceuticals, Inc.
Registration Number
NCT01008397
Locations
🇺🇸

Family Allergy and Asthma Research Institute, Louisville, Kentucky, United States

Clinical Trial of STAHIST in Seasonal Allergic Rhinitis Patients

Phase 1
Completed
Conditions
Rhinitis, Allergic, Seasonal
Interventions
Drug: STAHIST NDC #58407-536-01
First Posted Date
2009-07-03
Last Posted Date
2010-12-08
Lead Sponsor
Magna Pharmaceuticals, Inc.
Target Recruit Count
21
Registration Number
NCT00932256
Locations
🇺🇸

Family Allergy and Asthma Research Institute, Louisville, Kentucky, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.